The American Diabetes Association (ADA)“Standards of Care in Diabetes” includes the
ADA's current clinical practice recommendations and is intended to provide the components …

Background No clinical trials have assessed the effects or cost-effectiveness of health check
strategies to detect and manage vascular disease. We used a mathematical model to …

Background: Undetected/uncontrolled diabetes is associated with substantial morbidity and
mortality and consequent costs. Early detection through screening identifies patients at risk …

PURPOSE In screening for type 2 diabetes, guidelines recommend targeting high-risk
individuals. Our objectives were to assess the yield of opportunistic targeted screening for …

Objectives To assess the responsiveness of the National Health Insurance Fund (NHIF)
Supa Cover benefit package to the needs of individuals with diabetes and hypertension in …

More than 60% of the estimated 285 million people with diabetes globally are in low-and
middleincome countries (LMICs)(1). Largely driven by the growth of type 2 diabetes, the …

Background A multitarget stool DNA (mt-sDNA) test was recently approved for colorectal
cancer (CRC) screening for men and women, aged≥ 50 years, at average risk of CRC. The …

Aims/hypothesis Trials have not demonstrated benefits to the population of screening for
type 2 diabetes. However, there may be cost savings for those found to have diabetes. We …

Background Cardiometabolic diseases (CMD) are the major cause of death worldwide and
are associated with a lower quality of life and high healthcare costs. To prevent a further rise …

A growing body of evidence on diabetes screening has been published during the last 10
years. Type 2 diabetes meets many but not all of the criteria for screening. Concerns about …